Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Cholecystokinin receptor type A | ||
Ligand | BDBM50290399 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_50046 (CHEMBL662415) | ||
IC50 | 160±n/a nM | ||
Citation | Tabuchi, S; Ito, H; Sogabe, H; Kuno, M; Katsumi, I; Yamamoto, N; Mitsui, H; Satoh, Y Dual CCK-A and -B receptor antagonists (I) C9-methyl-1,4-benzodiazepines Bioorg Med Chem Lett7:169-174 (1997) Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Cholecystokinin receptor type A | |||
Name: | Cholecystokinin receptor type A | ||
Synonyms: | CCKAR_RAT | Cckar | Cholecystokinin peripheral | Cholecystokinin receptor | Cholecystokinin receptor type A | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 49676.37 | ||
Organism: | RAT | ||
Description: | Cholecystokinin central 0 RAT::P30551 | ||
Residue: | 444 | ||
Sequence: |
| ||
BDBM50290399 | |||
n/a | |||
Name | BDBM50290399 | ||
Synonyms: | 3-{3-[1-[2-(3-Aza-bicyclo[3.2.2]non-3-yl)-2-oxo-ethyl]-5-(2-fluoro-phenyl)-9-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-ureido}-benzoic acid | CHEMBL50926 | ||
Type | Small organic molecule | ||
Emp. Form. | C34H34FN5O5 | ||
Mol. Mass. | 611.6627 | ||
SMILES | Cc1cccc2c1N(CC(=O)N1CC3CCC(CC3)C1)C(=O)C(NC(=O)Nc1cccc(c1)C(O)=O)N=C2c1ccccc1F |c:40,(-1.23,-7.79,;-1.21,-9.34,;-2.54,-10.13,;-2.54,-11.67,;-1.21,-12.44,;.15,-11.67,;.15,-10.11,;1.28,-9.08,;.64,-7.66,;1.54,-6.42,;3.08,-6.56,;.89,-5,;-.62,-4.97,;-1.54,-3.74,;-.07,-4.14,;.15,-2.62,;1.59,-2.31,;.22,-1.59,;-1.17,-2.25,;1.91,-3.81,;2.85,-9.48,;3.8,-8.27,;3.52,-10.88,;4.86,-10.09,;6.21,-10.83,;6.21,-12.37,;7.54,-10.06,;9.08,-10.06,;9.83,-11.39,;11.35,-11.39,;12.12,-10.06,;11.35,-8.73,;9.81,-8.75,;12.12,-7.4,;13.66,-7.38,;11.32,-6.07,;2.85,-12.28,;1.36,-12.61,;1.03,-14.11,;-.46,-14.59,;-.81,-16.11,;.35,-17.16,;1.83,-16.67,;2.17,-15.17,;3.62,-14.68,)| | ||
Structure |